TY - JOUR
T1 - Improving health-related quality of life in patients with obstructive sleep apnea
T2 - What are the available options?
AU - Shah, Neomi
AU - Roux, Francoise
AU - Mohsenin, Vahid
N1 - Funding Information:
Funding for this work was, in part, from the Yale Center for Sleep Medicine. The authors have no conflicts of interest directly related to the contents of this paper.
PY - 2006
Y1 - 2006
N2 - Obstructive sleep apnea (OSA) syndrome is a common and often life-altering sleep-related breathing disorder. It not only adversely affects cardiovascular health, but the quality of life of these patients is also often significantly compromised. They experience excessive daytime sleepiness and poor cognitive, social and exercise performance. Furthermore, they often have marital problems with increased divorce rates, depression, and poor job performance. Our purpose in writing this review is to highlight the various neuropsychiatric domains that are affected in OSA patients and to emphasize that identifying and treating this condition can significantly improve the quality of life of these individuals. In recent years there has been ample evidence supporting the role of treatment for OSA to improve cardiovascular outcomes. We provide similar evidence supporting the treatment of OSA to improve health-related quality of life outcomes for these patients. Surgical, non-surgical and pharmacologic modalities are currently available as effective options for the treatment of OSA, with continuous positive airway pressure therapy appearing to be the most promising.
AB - Obstructive sleep apnea (OSA) syndrome is a common and often life-altering sleep-related breathing disorder. It not only adversely affects cardiovascular health, but the quality of life of these patients is also often significantly compromised. They experience excessive daytime sleepiness and poor cognitive, social and exercise performance. Furthermore, they often have marital problems with increased divorce rates, depression, and poor job performance. Our purpose in writing this review is to highlight the various neuropsychiatric domains that are affected in OSA patients and to emphasize that identifying and treating this condition can significantly improve the quality of life of these individuals. In recent years there has been ample evidence supporting the role of treatment for OSA to improve cardiovascular outcomes. We provide similar evidence supporting the treatment of OSA to improve health-related quality of life outcomes for these patients. Surgical, non-surgical and pharmacologic modalities are currently available as effective options for the treatment of OSA, with continuous positive airway pressure therapy appearing to be the most promising.
UR - http://www.scopus.com/inward/record.url?scp=33745899342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745899342&partnerID=8YFLogxK
U2 - 10.2165/00151829-200605040-00002
DO - 10.2165/00151829-200605040-00002
M3 - Review article
C2 - 16808543
AN - SCOPUS:33745899342
SN - 1176-3450
VL - 5
SP - 235
EP - 244
JO - Treatments in Respiratory Medicine
JF - Treatments in Respiratory Medicine
IS - 4
ER -